BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12861122)

  • 1. Treatment of symptomatic hyponatremia.
    Decaux G; Soupart A
    Am J Med Sci; 2003 Jul; 326(1):25-30. PubMed ID: 12861122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of severe hyponatremia (<120mEq/l)].
    Decaux G
    Rev Med Brux; 2001 Oct; 22(5):413-9. PubMed ID: 11723783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial.
    Baek SH; Jo YH; Ahn S; Medina-Liabres K; Oh YK; Lee JB; Kim S
    JAMA Intern Med; 2021 Jan; 181(1):81-92. PubMed ID: 33104189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of hyponatremia.
    Sterns RH; Nigwekar SU; Hix JK
    Semin Nephrol; 2009 May; 29(3):282-99. PubMed ID: 19523575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering.
    Soupart A; Penninckx R; Crenier L; Stenuit A; Perier O; Decaux G
    Kidney Int; 1994 Jan; 45(1):193-200. PubMed ID: 8127009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limits of brain tolerance to daily increments in serum sodium in chronically hyponatraemic rats treated with hypertonic saline or urea: advantages of urea.
    Soupart A; Stenuit A; Perier O; Decaux G
    Clin Sci (Lond); 1991 Jan; 80(1):77-84. PubMed ID: 1846795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms.
    Soupart A; Penninckx R; Stenuit A; Perier O; Decaux G
    J Neuropathol Exp Neurol; 1996 May; 55(5):594-601. PubMed ID: 8627349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline.
    Gankam Kengne F; Couturier BS; Soupart A; Decaux G
    Kidney Int; 2015 Feb; 87(2):323-31. PubMed ID: 25100046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
    Sood L; Sterns RH; Hix JK; Silver SM; Chen L
    Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study.
    Chifu I; Gerstl A; Lengenfelder B; Schmitt D; Nagler N; Fassnacht M; Weismann D
    Eur J Endocrinol; 2021 May; 184(5):647-655. PubMed ID: 33635825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications.
    Soupart A; Decaux G
    Clin Nephrol; 1996 Sep; 46(3):149-69. PubMed ID: 8879850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azotemia (48 h) decreases the risk of brain damage in rats after correction of chronic hyponatremia.
    Soupart A; Penninckx R; Stenuit A; Decaux G
    Brain Res; 2000 Jan; 852(1):167-72. PubMed ID: 10661508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low initial serum sodium level is associated with an increased risk of overcorrection in patients with chronic profound hyponatremia: a retrospective cohort analysis.
    Aratani S; Hara M; Nagahama M; Taki F; Futatsuyama M; Tsuruoka S; Komatsu Y
    BMC Nephrol; 2017 Oct; 18(1):316. PubMed ID: 29047375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis.
    Ayus JC; Krothapalli RK; Arieff AI
    Am J Med; 1985 Jun; 78(6 Pt 1):897-902. PubMed ID: 4014266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid correction of hyponatraemia with urea may protect against brain damage in rats.
    Van Reeth O; Decaux G
    Clin Sci (Lond); 1989 Sep; 77(3):351-5. PubMed ID: 2805597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective.
    Sterns RH; Cappuccio JD; Silver SM; Cohen EP
    J Am Soc Nephrol; 1994 Feb; 4(8):1522-30. PubMed ID: 8025225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.
    Vu T; Wong R; Hamblin PS; Zajac J; Grossmann M
    Hosp Pract (1995); 2009 Dec; 37(1):128-36. PubMed ID: 20877181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial).
    Lee A; Jo YH; Kim K; Ahn S; Oh YK; Lee H; Shin J; Chin HJ; Na KY; Lee JB; Baek SH; Kim S
    Trials; 2017 Mar; 18(1):147. PubMed ID: 28356136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats.
    Silver SM; Schroeder BM; Sterns RH; Rojiani AM
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):37-44. PubMed ID: 16410747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia.
    Woo CH; Rao VA; Sheridan W; Flint AC
    Neurocrit Care; 2009; 11(2):228-34. PubMed ID: 19533046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.